Anzu Special Acquisition Corp. I (ANZU) Adjourns Extension Meeting

Anzu Special Acquisition Corp I (Nasdaq: ANZU) announced this afternoon that it has once again adjourned its special meeting, scheduled for today, until February 28.

The SPAC was holding today’s meeting to extend its completion deadline by six months from March 4 up to September 30.

Anzu’s previously scheduled extension votes were also adjourned. However, earlier this morning Anzu disclosed its intent to sign an agreement with an insurance agent to cover the 1% excise tax liability, thereby maintaining the redemption value at $10.17.

Anzu investors also have its $150 million LOI with Envoy Medical to consider, which requires the SPAC to have at least $40 million in its trust in order for the deal to close. The US-based medical device company has developed and is in early clinical testing of fully implanted cochlear implants.